Amsterdam Molecular Therapeutics B.V
AMT Accesses Technology for Treatment of Duchenne Muscular Dystrophy
Published in Gene Therapy Weekly, June 5th, 2008
of human gene therapy, announced that it obtained a license from La Sapienza University in Rome, Italy, to their advanced small nuclear RNA (snRNA)-based exon-skipping technology for the treatment of Duchenne muscular dystrophy (DMD). The combination with AMT's proprietary adeno-associated virus (AAV) gene therapy platform potentially makes up a long-term treatment for this seriously debilitating disease with a single administration of the product.
Keywords: Biotechnology, Duchenne Muscular Dystrophy, Gene Therapy, Genetics, Genomics, Molecular Research, Molecular Therapies,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2008-06-05)
More Articles from Gene Therapy Weekly
- Federation of American Societies for Experimental Biology
Scientists 'paint' viruses to track their fate in the body - World Journal of Gastroenterology
A new change in the chromosome of patients with esophageal squamous cell carcinoma - World Journal of Gastroenterology
A potential route for human tumor gene therapy - World Journal of Gastroenterology
New prognostic markers for gastric cancer patients - Adrenocortical Cancer
Data on adrenocortical cancer published by researchers at University of California - Allergies
New allergies research from V. Casolaro et al outlined - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
